Annals of Emergency Medicine
Volume 45, Issue 3 , Pages 311-320 , March 2005

High Prevalence of Methicillin-Resistant Staphylococcus aureus in Emergency Department Skin and Soft Tissue Infections

Received 1 June 2004 ,Revised 21 September 2004 ,Accepted 4 October 2004.

References 

  1. Chambers HF. The changing epidemiology of Staphylococcus aureus?. Emerg Infect Dis. 2001;7:178–182
  2. Herold BC, Immergluck LC, Maranan MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA. 1998;279:593–598
  3. Frank AL, Marcinak JF, Mangat PD, et al. Increase in community-acquired methicillin-resistant Staphylococcus aureus in children. Clin Infect Dis. 1999;29:935–936
  4. Centers for Disease Control and Prevention . Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus: Minnesota and North Dakota, 1997-1999. JAMA. 1999;282:1123–1125
  5. Baba T, Takeuchi F, Kuroda M, et al. Genome and virulence determinants of high virulence community-acquired methicillin-resistant Staphylococcus aureus. Lancet. 2002;359:1819–1827
  6. Naimi TS, LeDell KH, Como-Sabetti K, et al. Comparison of community- and health care–associated methicillin-resistant Staphylococcus aureus infection. JAMA. 2003;290:2976–2984
  7. Dufour P, Gillet Y, Bes M, et al. Community-acquired methicillin-resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine leukocidin. Clin Infect Dis. 2002;35:819–824
  8. Diep BA, Sensabaugh GF, Somboona NS, et al. Widespread skin and soft-tissue infections due to two methicillin-resistant Staphylococcus aureus strains harboring the genes for Panton-Valentine leukocidin. J Clin Microbiol. 2004;42:2080–2084
  9. Salgado CD, Farr BM, Calfee DP. Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis. 2003;36:131–139
  10. Eady EA, Cove JH. Staphylococcal resistance revisited: community-acquired methicillin resistant Staphylococcus aureus: an emerging problem for the management of skin and soft tissue infections. Curr Opin Infect Dis. 2003;16:103–124
  11. Charlebois ED, Bangsberg DR, Moss NJ, et al. Population-based community prevalence of methicillin-resistant Staphylococcus aureus in the urban poor of San Francisco. Clin Infect Dis. 2002;34:425–433
  12. Outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections: Los Angeles County, California, 2002-2003. MMWR Morb Mortal Wkly Rep. 2003;52:88
  13. Methicillin-resistant Staphylococcus aureus infections among competitive sports participants: Colorado, Indiana, Pennsylvania, and Los Angeles County, 2000-2003. MMWR Morb Mortal Wkly Rep. 2003;52:793–795
  14. Groom AV, Wolsey DH, Naimi TS, et al. Community-acquired methicillin-resistant Staphylococcus aureus in a rural American Indian community. JAMA. 2001;286:1201–1205
  15. Baggett HC, Hennessy TW, Leman R, et al. An outbreak of community-onset methicillin-resistant Staphylococcus aureus skin infections in southwestern Alaska. Infect Control Hosp Epidemiol. 2003;24:397–402
  16. Pan ES, Diep BA, Carleton HA, et al. Increasing prevalence of methicillin-resistant Staphylococcus aureus infection in California jails. Clin Infect Dis. 2003;37:1384–1388
  17. Bannerman TL. Staphylococci and other catalase positive cocci that grow aerobically. In:  Murray PR,  Baron EJ,  Jogensen JH editor. Manual of Clinical Microbiology. 8th ed.. Washington, DC: ASM Press; 2003;p. 384–404
  18. National Committee on Clinical Laboratory Standards, NCfCLS . Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. 6th ed.. Wayne, PA: National Committee on Clinical Laboratory Standards; 2003;
  19. National Committee on Clinical Laboratory Standards, NCfCLS . Performance Standards for Antimicrobial Susceptibility Testing. 14th ed.. Wayne, PA: National Committee on Clinical Laboratory Standards; 2003;
  20. Fiebelkorn KR, Crawford SA, McElmeel ML, et al. Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci. J Clin Microbiol. 2003;41:4740–4744
  21. Vancomycin-intermediate resistant Staphylococcus aureus laboratory detection. Available at: http://www.cdc.gov/ncidod/hip/Lab/FactSheet/vrsa.htm. Accessed August 25, 2003.
  22. Liu C, Chambers HF. Staphylococcus aureus with heterogeneous resistance to vancomycin: epidemiology, clinical significance, and critical assessment of diagnostic methods. Antimicrob Agents Chemother. 2003;47:3040–3045
  23. Kim HB, Park WB, Lee KD, et al. Nationwide surveillance for Staphylococcus aureus with reduced susceptibility to vancomycin in Korea. J Clin Microbiol. 2003;41:2279–2281
  24. Diep BA, Perdreau-Remington F, Sensabaugh GF. Clonal characterization of Staphylococcus aureus by multilocus restriction fragment typing, a rapid screening approach for molecular epidemiology. J Clin Microbiol. 2003;41:4559–4564
  25. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33:2233–2239
  26. Enright MC, Day NP, Davies CE, et al. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol. 2000;38:1008–1015
  27. Carleton HA, Diep BA, Charlebois ED, et al. Community-adapted methicillin-resistant Staphylococcus aureus: population dynamics of an expanding community reservoir of MRSA. J Infect Dis. 2004;190:1730–1738
  28. Oliveira DC, de Lencastre H. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2002;46:2155–2161
  29. Vandenesch F, Naimi T, Enright MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis. 2003;9:978–984
  30. Fleiss JL. Statistical Methods for Rates and Proportions. 2nd ed.. New York, NY: Wiley; 1981;
  31. Ma XX, Ito T, Tiensasitorn C, et al. Novel type of staphylococcal cassette chromosome mec identified in community-acquired methicillin-resistant Staphylococcus aureus strains. Antimicrob Agents Chemother. 2002;46:1147–1152
  32. Saravolatz LD, Markowitz N, Arking L, et al. Methicillin-resistant Staphylococcus aureus: epidemiologic observations during a community-acquired outbreak. Ann Intern Med. 1982;96:11–16
  33. Sattler CA, Mason EO, Kaplan SL. Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children. Pediatr Infect Dis J. 2002;21:910–917
  34. Jernigan JA, Pullen AL, Partin C, et al. Prevalence of and risk factors for colonization with methicillin-resistant Staphylococcus aureus in an outpatient clinic population. Infect Control Hosp Epidemiol. 2003;24:445–450
  35. Grundmann H, Tami A, Hori S, et al. Nottingham Staphylococcus aureus population study: prevalence of methicillin-resistant Staphylococcus aureus among elderly people in the community. BMJ. 2002;324:1365–1366
  36. Ala'Aldeen D. A non-multiresistant community methicillin-resistant Staphylococcus aureus exposes its genome. Lancet. 2002;359:1791–1792
  37. Kallen AJ, Driscoll TJ, Thornton S, et al. Increase in community-acquired methicillin-resistant Staphylococcus aureus at a Naval Medical Center. Infect Control Hosp Epidemiol. 2000;21:223–226
  38. Fergie JE, Purcell K. Community-acquired methicillin-resistant Staphylococcus aureus infections in south Texas children. Pediatr Infect Dis J. 2001;20:860–863
  39. Caputo GM, Cavanagh PR, Ulbrecht JS, et al. Assessment and management of foot disease in patients with diabetes. N Engl J Med. 1994;331:854–860
  40. Meislin HW, Lerner SA, Graves MH, et al. Cutaneous abscesses: anaerobic and aerobic bacteriology and outpatient management. Ann Intern Med. 1977;87:145–149
  41. Summanen PH, Talan DA, Strong C, et al. Bacteriology of skin and soft-tissue infections: comparison of infections in intravenous drug users and individuals with no history of intravenous drug use. Clin Infect Dis. 1995;20(Suppl 2):S279–S282
  42. Nishijima S, Kurokawa I. Antimicrobial resistance of Staphylococcus aureus isolated from skin infections. Int J Antimicrob Agents. 2002;19:241–243
  43. Methicillin-resistant Staphylococcus aureus infections in correctional facilities: Georgia, California, and Texas, 2001-2003. MMWR Morb Mortal Wkly Rep. 2003;52:992–996
  44. Swartz MN. Clinical practice: cellulitis. N Engl J Med. 2004;350:904–912
  45. Sanford MD, Widmer AF, Bale MJ, et al. Efficient detection and long-term persistence of the carriage of methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 1994;19:1123–1128
  46. McGehee RR, Barre FF, Finland M. Resistance of Staphylococcus aureus to lincomycin, clinimycin, and erythromycin. Antimicrobial Agents Chemother. 1968;8:392–397
  47. Marcinak JF, Frank AL. Treatment of community-acquired methicillin-resistant Staphylococcus aureus in children. Curr Opin Infect Dis. 2003;16:265–269
  48. Panagea S, Perry JD, Gould FK. Should clindamycin be used as treatment of patients with infections caused by erythromycin-resistant staphylococci?. J Antimicrob Chemother. 1999;44:581–582
  49. Frank AL, Marcinak JF, Mangat PD, et al. Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children. Pediatr Infect Dis J. 2002;21:530–534
  50. Drinkovic D, Fuller ER, Shore KP, et al. Clindamycin treatment of Staphylococcus aureus expressing inducible clindamycin resistance. J Antimicrob Chemother. 2001;48:315–316
  51. Baggett HC, Hennessy TW, Rudolph K, et al. Community-onset methicillin-resistant Staphylococcus aureus associated with antibiotic use and the cytotoxin Panton-Valentine leukocidin during a furunculosis outbreak in rural Alaska. J Infect Dis. 2004;189:1565–1573
  52. Lina G, Piemont Y, Godail-Gamot F, et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis. 1999;29:1128–1132
  53. Barrett TW, Moran GJ. Methicillin-resistant Staphylococcus aureus infections among competitive sports participants—Colorado, Indiana, Pennsylvania, and Los Angeles County, 2000-2003. Ann Emerg Med. 2004;43:43–45
  54. Okuma K, Iwakawa K, Turnidge JD, et al. Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community. J Clin Microbiol. 2002;40:4289–4294
  55. Daum RS, Ito T, Hiramatsu K, et al. A novel methicillin-resistance cassette in community-acquired methicillin-resistant Staphylococcus aureus isolates of diverse genetic backgrounds. J Infect Dis. 2002;186:1344–1347
  56. Gillet Y, Issartel B, Vanhems P, et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet. 2002;359:753–759
  57. McDougal LK, Steward CD, Killgore GE, et al. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J Clin Microbiol. 2003;41:5113–5120
  58. Shinefield H, Black S, Fattom A, et al. Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis. N Engl J Med. 2002;346:491–496

 Author contributions: BWF conceived the study. BWF, JL, LL, EDC, and FPR all contributed to study design. BWF, JL, and DL recruited patients and managed data. LL oversaw bacteriology. FPR oversaw genotyping. EDC provided statistical support and expertise. EDC, JL, BWF, and FPR analyzed the data. BWF drafted the manuscript, and all authors contributed to its revision. BWF takes responsibility for the paper as a whole.Funding and support: The authors report this study did not receive any outside funding or support.Presented as a poster at the Western Regional Society for Academic Emergency Medicine Scientific Assembly, Oakland, CA, April 2004; and the Society for Academic Emergency Medicine National Scientific Assembly, Orlando, FL, March 2004.Reprints not available from the authors.

PII: S0196-0644(04)01505-7

doi: 10.1016/j.annemergmed.2004.10.011

Annals of Emergency Medicine
Volume 45, Issue 3 , Pages 311-320 , March 2005

Article Tools

* Image Usage & Resolution